East West Detox: BBC News Interview
East West Detox: BBC News Interview – www.east-westdetox.org.uk Mike Sarson, the charities founder, interviewed live on BBC South Today. East-West Detox charitable trust was founded and established by professional workers in the drug field, who felt that there was a need for a different kind of service provision, concerning the detoxification and rehabilitation of problematic substance users. A new model of treatment that combines both eastern and western philosophies, as well as therapy and medicine. This service provision means that there is now a wider choice, so that an individual can choose the treatment that suits them best. Our aim is to enable and empower British individuals whose quality of life is affected by substance misuse and to undertake a holistic programme of natural, herbal detoxification and rehabilitation to help people develop their potential and reintegrate. East-West Detox facilitates access to a unique treatment for substance addiction that has been carried out by monks at the Thamkrabok Monastery in Thailand since 1957, where over 100000 people have engaged in the programme. The detoxification process, using a combination of over a hundred herbs and plant extracts, takes only 5 days and is administered as a drink daily. This is complemented by other therapies including herbal steam baths, diet and nutrition with counselling,guidance and mindfulness meditation for relapse prevention. This unique programme is non chemical and does not replace one addictive substance for another. The …
Addiction treatment shouldn't succumb to NIMBY logic
Filed under: drug treatment news
Finally, Hernando County residents fighting drug addiction will have a place closer to home to get help. And county commissioners should learn their lesson about succumbing to not-in-my-backyard arguments when it comes to land-use decisions. Last week …
Read more on Tampabay.com
Biogen: New data support BG-12 as MS treatment
Filed under: drug treatment news
Most treatments for the chronic, inflammatory and potentially disabling disease are delivered by needle, but BG-12, or dimethyl fumarate, is an oral drug that will likely be taken twice daily. The drug is currently under review with U.S. and European …
Read more on MarketWatch